Imunon (IMNN) said Monday it submitted a plan to Nasdaq to regain compliance with the minimum bid price and stockholders' equity requirements for continued listing on the Nasdaq Capital Market.
The company said it expects to receive an additional 180-day compliance period, subject to final review by a Nasdaq Hearings Panel.
Following several recent transactions, Imunon said its stockholders' equity as of May 31 exceeded $3.0 million, above the threshold required for continued listing.
Shares of Imunon were up more than 8% in recent trading.
Price: 0.80, Change: +0.06, Percent Change: +8.51
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.